Ion Channels: Solving a specificity mystery
Being able to quickly respond to danger is an essential survival skill. In humans, the sympathetic branch of the autonomic nervous system is responsible for the body’s ‘fight-or-flight’ response. It activates the physiological changes we perceive as an adrenaline rush, including a rapid increase in heart rate mediated by beta adrenergic receptors in the pacemaker cells of the heart. When the danger has passed, the parasympathetic branch of the nervous system activates an alternative ‘rest-and-digest’ program, which slows down the heart by activating other receptors called muscarinic acetylcholine receptors.
Despite their opposite effects, these receptors are both G protein-coupled receptors (GPCRs). When activated, the receptors in this family signal by causing a G protein to split into a Gα subunit and a Gβγ subunit (Figure 1). A G protein can have a Gαs or a Gαi/o subunit, among other possibilities. Beta adrenergic receptors prefer to interact with G proteins that contain the former, whereas muscarinic acetylcholine receptors (M2Rs) favor G proteins that contain the latter. A longstanding mystery in cell biology is why the Gβγ subunits released by M2Rs are able to activate potassium channels called GIRKs, which causes the heart rate to drop, whereas the same Gβγ subunits released by beta adrenergic receptors cannot (Dascal, 1997).

Activation of the GIRK ion channel.
Two types of G protein-coupled receptors – the muscarinic acetylcholine receptors and the beta adrenergic receptors – are key regulators of heart rate. When these receptors are activated, G proteins inside the cell split into two subunits, Gα (pale blue ovals) and Gβγ (green/purple circles). The release of adrenaline, for example, results in the activation of beta adrenergic receptors (βARs; bottom) by adrenaline (red circle) to increase the heart rate. The activation of a muscarinic acetylcholine receptor (M2R; top) by acetylcholine (red star) leads to the activation of GIRK ion channels and a subsequent drop in heart rate. It has been unclear why the Gβγ subunits released by M2Rs could activate GIRK channels, whereas the same Gβγ subunits released by βARs could not. Touhara and MacKinnon suggest that the fast kinetics of interactions between G proteins containing Gαi/o subunits and M2Rs releases high enough concentrations of Gβγ subunits to activate the GIRK channels (top). The interactions between G proteins containing Gαs subunits and βARs, on the other hand, are slower and cannot produce enough Gβγ subunits before they diffuse away or rebind to the Gαs subunits (bottom).
One possibility is that M2Rs and GIRKs can form large complexes, which means that the M2Rs could release the Gβγ subunits right where they are needed (Clancy et al., 2005; Riven et al., 2006), whereas beta adrenergic receptors and GIRKs may not form such complexes and therefore would not benefit from a proximity effect. Now, in eLife, Kouki Touhara and Roderick MacKinnon of the Rockefeller University report that the mystery has a different solution (Touhara and MacKinnon, 2018).
Touhara and MacKinnon assessed whether the specificity of GIRKs for M2Rs compared to beta adrenergic receptors is universal, confirming that only M2Rs could activate the potassium channels regardless of the cell line tested. They also showed that the formation of a M2R-GIRK complex was neither necessary nor sufficient to explain why Gβγ subunits released by M2Rs can activate GIRKs and those released by beta adrenergic receptors cannot. So, what, then, is the explanation?
The next clue came from investigating the effect of G protein levels on GIRK signaling. Touhara and MacKinnon confirmed that when native levels of G proteins were present, only M2Rs could activate GIRK channels. However, when Gαsβγ levels were increased, beta adrenergic receptors were also able to activate the channels. These results even extended to non-GIRK channels, in which the researchers find the same pattern, further suggesting that under normal conditions the limited availability of G proteins allows M2Rs to selectively modulate ion channels.
To better understand the role of G protein levels, the rate at which each receptor causes Gβγ to split from Gα was measured. This revealed that M2Rs break up G proteins more quickly than adrenergic receptors do. With this information in hand, a mathematical model was constructed, incorporating previously measured values for reaction rates. The results suggest that the specific GIRK-GPCR signaling could be because G proteins containing Gαi/o subunits associate more quickly with M2Rs than the G proteins that contain Gαs subunits do with beta adrenergic receptors. This results in M2Rs liberating Gβγ subunits more quickly so that they accumulate to the high levels required for GIRK activation, and could explain how differences in a single association-rate constant can allow the parasympathetic and sympathetic branches of the nervous system to control heart rate without interfering with each other (Figure 1).
While the kinetic model offers a nearly complete picture, Touhara and MacKinnon point out that their model required a higher receptor concentration than expected. This is consistent with previous work showing that GPCRs may be preferentially concentrated in local ‘hotspot’ regions of the cell membrane (Sungkaworn et al., 2017). This could offer yet another level of regulation, providing an exciting avenue for future research. Other areas to explore include the molecular basis for the fast association of Gαiβγ with M2Rs, and how other GPCR-GIRK signaling systems have been tuned for the diverse biological roles they play.
References
-
Signalling via the G protein-activated K+ channelsCellular Signalling 9:551–573.https://doi.org/10.1016/S0898-6568(97)00095-8
Article and author information
Author details
Publication history
Copyright
© 2019, Zheng and Kruse
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,898
- views
-
- 186
- downloads
-
- 0
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Plant Biology
- Structural Biology and Molecular Biophysics
The Calvin-Benson-Bassham cycle (CBBC) performs carbon fixation in photosynthetic organisms. Among the eleven enzymes that participate in the pathway, sedoheptulose-1,7-bisphosphatase (SBPase) is expressed in photo-autotrophs and catalyzes the hydrolysis of sedoheptulose-1,7-bisphosphate (SBP) to sedoheptulose-7-phosphate (S7P). SBPase, along with nine other enzymes in the CBBC, contributes to the regeneration of ribulose-1,5-bisphosphate, the carbon-fixing co-substrate used by ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco). The metabolic role of SBPase is restricted to the CBBC, and a recent study revealed that the three-dimensional structure of SBPase from the moss Physcomitrium patens was found to be similar to that of fructose-1,6-bisphosphatase (FBPase), an enzyme involved in both CBBC and neoglucogenesis. In this study we report the first structure of an SBPase from a chlorophyte, the model unicellular green microalga Chlamydomonas reinhardtii. By combining experimental and computational structural analyses, we describe the topology, conformations, and quaternary structure of Chlamydomonas reinhardtii SBPase (CrSBPase). We identify active site residues and locate sites of redox- and phospho-post-translational modifications that contribute to enzymatic functions. Finally, we observe that CrSBPase adopts distinct oligomeric states that may dynamically contribute to the control of its activity.
-
- Biochemistry and Chemical Biology
- Structural Biology and Molecular Biophysics
African trypanosomes are the causative agents of neglected tropical diseases affecting both humans and livestock. Disease control is highly challenging due to an increasing number of drug treatment failures. African trypanosomes are extracellular, blood-borne parasites that mainly rely on glycolysis for their energy metabolism within the mammalian host. Trypanosomal glycolytic enzymes are therefore of interest for the development of trypanocidal drugs. Here, we report the serendipitous discovery of a camelid single-domain antibody (sdAb aka Nanobody) that selectively inhibits the enzymatic activity of trypanosomatid (but not host) pyruvate kinases through an allosteric mechanism. By combining enzyme kinetics, biophysics, structural biology, and transgenic parasite survival assays, we provide a proof-of-principle that the sdAb-mediated enzyme inhibition negatively impacts parasite fitness and growth.